Industrial CDx Partnerships
In addition to those assays in our portfolio (see Our Assays, to find out more) we also offer custom assay creation to report on specific PPI or PTM targets of your interest. We understand the obstacles that can hinder the creation of new assays, which is why our validated QF-Pro® technology presents a perfect way to answer novel scientific questions, providing research and translational medicine teams with the power of functional, quantifiable biomarkers for supporting the development of new drug targets and treatments.
We offer QF-Pro® products and assays as companion diagnostic tools for the lifetime of a drug:
- providing new routes to elucidate biologically relevant biomarkers based on protein function
- for the functional shortlisting of targets and mechanistic observation of the MoA of drugs in tissues and cell lines
- as a patient stratification tool for phase I to phase IV trials and, potentially, for patient stratification in commercial treatments in clinical use.
At HAWK Biosystems, we thrive on research partnerships and are constantly seeking to work in tandem with clinicians, researchers and academics alike. We have undertaken multiple partnerships with a range of universities and research organisations across several continents.
HAWK Biosystems hosts multiple masters’ placements from students from the University of the Basque Country
(UPV/EHU), University of Bath
, and the University of Bristol
. HAWK Biosystems also hosts PhD students from a range of different academic backgrounds.
HAWK Biosystems are constantly striving to inspire, train and promote young scientists in a multidisciplinary manner that spans both academia and industry.